207713
1,3-Di-o-tolylguanidine
99%
Synonym(s):
DTG
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
(CH3C6H4NH)2C(=NH)
CAS Number:
Molecular Weight:
239.32
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
202-577-6
MDL number:
Assay:
99%
Form:
solid
Quality Level
assay
99%
form
solid
mp
176-178 °C (lit.)
solubility
water: soluble 70 mg/mL at 20 °C
functional group
amine
SMILES string
Cc1ccccc1NC(=N)Nc2ccccc2C
InChI
1S/C15H17N3/c1-11-7-3-5-9-13(11)17-15(16)18-14-10-6-4-8-12(14)2/h3-10H,1-2H3,(H3,16,17,18)
InChI key
OPNUROKCUBTKLF-UHFFFAOYSA-N
Gene Information
human ... EBP(10682)
General description
1,3-Di-o-tolylguanidine is a selective σ-receptor agonist. 1,3-Di-o-tolylguanidine is σ site ligand and its interaction with dopamine drugs were studied in Wistar rats and Albino Swiss mice.
Regulatory Listings
Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.
Substances Subject to be Indicated Names
ishl_indicated
Substances Subject to be Notified Names
ishl_notified
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
S A Mousavi et al.
Ultrasonics sonochemistry, 46, 26-35 (2018-05-10)
A nanostructured cationic zinc nitrate complex with a formula of [ZnLNO3]NO3 (where L = (N2E,N2'E)-N1,N1'-(ethane-1,2-diyl)bis(N2-((E)-3-phenylallylidene)ethane-1,2-diamine)) was prepared by sonochemical process and characterized by single crystal X-ray crystallography, scanning electron microscopy (SEM), FT-IR and NMR spectroscopy and X-ray powder diffraction (XRPD). The X-ray
Tomokazu Yoshinaga et al.
Antiviral research, 152, 1-9 (2018-02-08)
Cabotegravir (CAB, S/GSK1265744) is an investigational second-generation integrase strand transfer inhibitor (INSTI) with a chemical structure similar to dolutegravir. CAB is under development as a long-acting injectable formulation for treatment of HIV-1 infection and for pre-exposure prophylaxis. We conducted an
Martina Kovarova et al.
Nature communications, 9(1), 4156-4156 (2018-10-10)
Non-adherence to medication is an important health care problem, especially in the treatment of chronic conditions. Injectable long-acting (LA) formulations of antiretrovirals (ARVs) represent a viable alternative to improve adherence to HIV/AIDS treatment and prevention. However, the LA-ARV formulations currently